Is High-Voltage Lead Integrity Measurement Adequate During Defibrillator Generator Replacement ?

The necessity for defibrillator testing at the time of implant or generator replacement is widely debated. The need for administering a shock at time of implant is lessened by the use of high-voltage integrity checks commonly employed by all device manufacturers. We report a case of a patient with a lead under safety advisory (St. Jude Riata 1580) and known externalization of conductors with no prior electrical abnormalities who underwent routine generator replacement. After the generator replacement, the high-voltage integrity check was normal, but during defibrillator testing the device was unable to deliver high-voltage therapy after successful induction of ventricular fibrillation. This was repeated after reinterrogation of the device, again showing normal high-voltage integrity and once again it failed to deliver life-saving therapy. Both failures were a result of a low impedance, and subsequent interrogation revealed nondetectable impedance consistent with a short in the high-voltage circuit. Lead analysis revealed a short in the high-voltage circuit not related to externalization of conductor wires. This case illustrates the importance of delivering an actual high-voltage shock to determine the circuit integrity for a defibrillator system at time of implant or replacement.

[1]  C. Schuger,et al.  Failure to Deliver Therapy by a Riata Lead with Internal Wire Externalization and Normal Electrical Parameters During Routine Interrogation , 2013, Journal of cardiovascular electrophysiology.

[2]  R. Hauser,et al.  Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. , 2012, Heart rhythm.

[3]  R. Hauser,et al.  Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. , 2012, Heart rhythm.

[4]  S. Massimo,et al.  Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project. , 2011, American heart journal.

[5]  M. Santini,et al.  Can we predict and prevent adverse events related to high-voltage implantable cardioverter defibrillator lead failure? , 2011, Journal of Interventional Cardiac Electrophysiology.

[6]  Dominique Lacroix,et al.  Contributions of remote monitoring to the follow-up of implantable cardioverter–defibrillator leads under advisory , 2010, European heart journal.

[7]  Christopher R. Ellis,et al.  Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. , 2009, Heart rhythm.

[8]  S. Greenberg,et al.  Performance of the St. Jude Medical Riata leads. , 2009, Heart rhythm.

[9]  D. Mark,et al.  No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). , 2008, Journal of the American College of Cardiology.

[10]  C. Gornick,et al.  Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. , 2008, Heart rhythm.

[11]  D. Massel,et al.  Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov Model , 2008, Journal of cardiovascular electrophysiology.

[12]  J. Healey,et al.  Complications associated with defibrillation threshold testing: the Canadian experience. , 2008, Heart rhythm.

[13]  C. Gornick,et al.  Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. , 2007, Heart rhythm.

[14]  G. Klein,et al.  Is defibrillation testing required for defibrillator implantation? , 2004, Journal of the American College of Cardiology.

[15]  C. Swerdlow Reappraisal of implant testing of implantable cardioverter defibrillators. , 2004, Journal of the American College of Cardiology.

[16]  F. Morady,et al.  Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. , 1997, Circulation.

[17]  E. Gang,et al.  Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. , 1994, Circulation.